Biblio
Outcomes with Allogeneic Hematopoietic Stem Cell Transplantation in TP53-mutated Myelodysplastic syndrome: A Systematic Review and Meta-Analysis. Crit Rev Oncol Hematol. 2024:104310.
Targeting inflammation in lower-risk MDS. Hematology Am Soc Hematol Educ Program. 2022;2022(1):382-387.
.